2,030
Views
8
CrossRef citations to date
0
Altmetric
Technical Note

On measurements of glucagon secretion in healthy, obese, and Roux-en-Y gastric bypass operated individuals using sandwich ELISA

ORCID Icon, , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 75-83 | Received 05 Sep 2021, Accepted 06 Dec 2021, Published online: 22 Dec 2021

References

  • Albrechtsen NJW, Kuhre RE, Pedersen J, et al. The biology of glucagon and the consequences of hyperglucagonemia. Biomark Med. 2016;10(11):1141–1151.
  • Janah L, Kjeldsen S, Galsgaard KD, et al. Glucagon receptor signaling and glucagon resistance. Int J Mol Sci. 2019;20(13):3314.
  • Albrechtsen NJW. The glucose-mobilizing effect of glucagon at fasting is mediated by cyclic AMP. Am J Physiol Endocrinol Metab. 2021;321(4):E571–E574.
  • Holst JJ, Wewer Albrechtsen NJ. Methods and guidelines for measurement of glucagon in plasma. Int J Mol Sci. 2019;20(21).
  • Wewer Albrechtsen NJ, Kuhre RE, Hornburg D, et al. Circulating glucagon 1-61 regulates blood glucose by increasing insulin secretion and hepatic glucose production. Cell Rep. 2017;21(6):1452–1460.
  • Wewer Albrechtsen NJ, Hornburg D, Albrechtsen R, et al. Oxyntomodulin identified as a marker of type 2 diabetes and gastric bypass surgery by mass-spectrometry based profiling of human plasma. EBioMedicine. 2016;7:112–120.
  • Holst JJ. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J. 1982;207(3):381–388.
  • Bak M, Albrechtsen Wewer N, Pedersen J, et al. Specificity and sensitivity of commercially available methods for the measurement of human glucagon, oxyntomodulin and glicentin; 2013.
  • Wewer Albrechtsen NJ, Hartmann B, Veedfald S, et al. Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? Diabetologia. 2014;57(9):1919–1926.
  • Albrechtsen NJW, Kuhre RE, Windeløv JA, et al. Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes. Am J Physiol Endocrinol Metab. 2016;311(2):E302–E309.
  • Roberts GP, Kay RG, Howard J, et al. Gastrectomy with roux-en-Y reconstruction as a lean model of bariatric surgery. Surg Obes Relat Dis. 2018;14(5):562–568.
  • Jorsal T, Wewer Albrechtsen NJ, Christensen MM, et al. Investigating intestinal glucagon after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab. 2019;104(12):6403–6416.
  • Jensen CZ, Bojsen-Møller KN, Svane MS, et al. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol. 2020;318(4):G661–g672.
  • Martinussen C, Veedfald S, Dirksen C, et al. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery. Am J Physiol Endocrinol Metab. 2020;318(6):E956–E964.
  • Cegla J, Jones BJ, Howard J, et al. The preanalytical stability of glucagon as measured by liquid chromatography tandem mass spectrometry and two commercially available immunoassays. Ann Clin Biochem. 2017;54(2):293–296.
  • Wewer Albrechtsen NJ, Veedfald S, Plamboeck A, et al. Inability of some commercial assays to measure suppression of glucagon secretion. J Diabetes Res. 2016;2016:8352957.